Summit Therapeutics Inc.
USD14.52
+0.20 (+1.40%)
CEO
Robert W. Duggan
IPO Date
2015-03-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.32
Prev. Close
$14.32
Day Low
$14.31
Day High
$14.89
52W Low
$12.55
52W High
$30.98
Market Cap
$11.27B
Volume
3.01M
| -72.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -784.6% | -300.3% | 1.37 | 9.30 | -3.4 |
| 31 Dec 2022 | FY | 100.0% | -11174.8% | -63.1% | -12.0% | 4.10 | 16.93 | -12.5 |
| 31 Dec 2021 | FY | 100.0% | -4897.8% | -106.1% | -78.0% | 0.03 | 3.80 | -3.8 |
| 31 Dec 2020 | FY | 100.0% | -6127.6% | -66.0% | -51.2% | 0.01 | 4.41 | -8.5 |
| 31 Dec 2019 | FY | 100.0% | -3920.2% | -39.2% | -31.8% | 0.01 | 6.27 | -1.6 |
| 31 Jan 2019 | FY | 98.8% | 19.0% | 19.5% | 13.7% | 0.00 | 3.56 | 8.0 |
| 31 Jan 2018 | FY | 100.0% | -142.3% | 451.8% | -25.8% | 0.00 | 1.56 | -31.2 |
| 31 Jan 2017 | FY | 100.0% | -899.5% | 489.5% | -45.5% | 0.00 | 3.06 | -23.8 |
| -15.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -162.2% | -119.1% | 0.03 | 3.80 | -16.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -216.5% | -173.3% | 0.02 | 5.13 | -9.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -18.3% | -16.4% | 0.02 | 10.63 | -69.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -15.7% | -14.0% | 0.02 | 10.15 | -62.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -12.6% | -11.0% | 0.07 | 8.31 | -91.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -31.0% | -17.7% | 0.56 | 2.35 | -28.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -97.8% | -24.5% | 2.48 | 6.97 | -20.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -46.7% | -17.9% | 1.37 | 9.30 | -15.9 |